Melanoma brain metastases outcomes following nivolumab and relatlimab after ipilimumab and nivolumab progression
Fuente:
PubMed "nature biotechnology"
J Neurooncol. 2026 Mar 9;177(1):35. doi: 10.1007/s11060-026-05510-w.NO ABSTRACTPMID:41801545 | DOI:10.1007/s11060-026-05510-w